Mouse EGF Protein, Fc Tag

Proteins and Peptides

貨號 Cat. No.
EGF-M5265
規格 Size
1mg
品牌 Brand
ACROBiosystems
Species
Mouse
Conjugate
Unconjugated
Expression System
HEK293
Tag
Fc Tag

Description




Source : 


Mouse EGF, Fc Tag (EGF-M5265) is expressed from human 293 cells (HEK293). It contains AA Asn 977 - Arg 1029 (Accession # P01132-1).


 

Molecule : EGF


 

Synonyms : EGF,URG,HOMG4


 

Format : Powder


 

Category : Cytokines&Growth Factors


 

Accession : NP_034243.2


 

Storage : -20℃


 

Shipping condition : Powder,RT


 

Molecular Weight : 32.5 kDa


 

Characteristics :


This protein carries a human IgG1 Fc tag at the N-terminus. The protein has a calculated MW of 32.5 kDa. The protein migrates as 35 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.


 

Endotoxin Level : Less than 1.0 EU per μg by the LAL method.


 

Buffer : Tris with Glycine, Arginine and NaCl, pH7.5


 

Description :


Human epidermal growth factor (EGF) is also known as HOMG4 and  URG,and is a growth factor that plays an important role in the regulation of cell growth, proliferation, and differentiation by binding to its receptor EGFR. Epidermal growth factor can be found in human platelets, macrophages, urine, saliva, milk, and plasma. EGF is the founding member of the EGF-family of proteins. Members of this protein family have highly similar structural and functional characteristics. All family members contain one or more repeats of the conserved amino acid sequence. The biological effects of salivary EGF include healing of oral and gastroesophageal ulcers, inhibition of gastric acid secretion, stimulation of DNA synthesis as well as mucosal protection from intraluminal injurious factors such as gastric acid, bile acids, pepsin, and trypsin and to physical, chemical and bacterial agents. Because of the increased risk of cancer by EGF, inhibiting it decreases cancer risk.


 

References :


(1) Barnham KJ,et al. 1998, Protein Science 7 (8): 1738–49.
(2) Cotran, Ramzi S.,et al. 2005, Robbins and Cotran pathologic basis of disease.
(3) Dreux AC,et al. 2006, Atherosclerosis 186 (1): 38–53.
(4) Venturi S,et al.2009, Nutrition and Health 20 (2): 119–134.
(5) Herbst RS.et al.2004, International Journal of Radiation Oncology, Biology, Physics 59 (2 Suppl): 21–6.





詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢